Benznidazol (Synonyms: Ro 07-1051; Ro 71051)|CAS 22994-85-0|DC Chemicals

Cas No.:	22994-85-0
Chemical Name:	Benznidazol
Synonyms:	1H-Imidazole-1-acetamide,2-nitro-N-(phenylmethyl)-;Benznidazole;N-Benzyl-2-Nitro-1H-Imidazole-1-Acetamide;N-benzyl-2-(2-nitroimidazol-1-yl)acetamide;Radanil;Benzonidazole;Benznidazol;benzonidazol;Benznidazolum;N-Benzyl-2-nitroimidazole-1-acetamide;N-Benzyl-2-nitroimidazol-1-yl-acetamide;Rochagan;Benznidazolum [INN-Latin];Benznidazol [INN-Spanish];1H-Imidazole-1-acetamide, 2-nitro-N-(phenylmethyl)-;Ro 71051;N-benzyl-2-(2-nitro-1H-imidazol-1-yl)acetamide;2-Nitro-N-(phenylmethyl)-1H-imidazole-1-acetamide;Imidazole-1-acetamide, N-be;Ro 07-1051;N-Benzyl-2-nitro-1H-imidazole-1-acetamide;1H-Imidazole-1-acetamide, 2-nitro-N-(phenylmethyl)- [;CS-0013411;CCG-267054;BENZNIDAZOLE (MART.);AKOS024283499;Tox21_112364;N-benzyl-2-(2-nitro-1Himidazol-1-yl)acetamide;MLS001360496;CHEMBL110;J-014932;P01CA02;benznidazole (TN);HMS3369C11;BDBM50089916;Benznidazole [INN];BENZNIDAZOLE [USAN];BENZNIDAZOLE [ORANGE BOOK];NSC-299972;AS-68694;1H-Imidazole-1-acetamide,2-Nitro-n-(phenylmethyl)-;D02489;YC42NRJ1ZD;SR-01000841264;NSC 299972;NSC299972;Benznidazolum (INN-Latin);N-benzyl-2-nitro-1-imidazoleacetamide;SR-01000841264-3;C74184;CCRIS 2200;Rochagan (TN);RO-07-1051;Imidazole-1-acetamide, N-benzyl-2-nitro-;A912716;BENZNIDAZOLUM [WHO-IP LATIN];22994-85-0;BRD-K56156805-001-05-4;Acetamide, N-benzyl-2-(nitroimidazol-1-yl)-;SMR000857153;HMS2233G13;Pyridinium,1-dodecyl-2-[(hydroxyimino)methyl]-,iodide(1:1);NCGC00166238-01;DTXCID7026570;MLS001332409;EN300-1716737;HY-B1548;s3741;N-Benzyl-2-(2-nitro-imidazol-1-yl)-acetamide;CHEBI:133833;UNII-YC42NRJ1ZD;DB11989;Q425300;CAS-22994-85-0;Ragonil;MMV688773;MFCD00243089;Benznidazol (INN-Spanish);MLS001332410;BENZNIDAZOLE;AKOS015916722;SCHEMBL45081;BENZNIDAZOLE [MART.];Ro 07-1051;Ro 71051;SCHEMBL22493029;Tox21_112364_1;NS00068191;NCGC00166238-02;BENZNIDAZOLE [MI];N-Benzyl-2-(2-nitro-imidazol-1-yl)-acetamide (Benznidazole);SR-01000841264-4;BENZNIDAZOLE [WHO-IP];BENZNIDAZOLE [WHO-DD];Z2044771577;DTXSID9046570;Radanil (TN);Benznidazol (Ro 07-1051; Ro 71051);BRN 0551486;Ro-7-1051;N-benzyl-2-(2-nitro-1H-imidazol-5-yl)acetamide;N-Benzyl-2-nitro-1H-imidazole-1-acetamide, 97%;FT-0662547;Benznidazole (USAN/INN);Benznidazole [USAN:INN]
SMILES:	O=C(C([H])([H])N1C([H])=C([H])N=C1[N+](=O)[O-])N([H])C([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H]
Formula:	C₁₂H₁₂N₄O₃
M.Wt:	260.2487
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

In Vivo Benznidazole (100 mg/kg/day, p.o., 30 days) produces a decrease in electrocardiographic alterations, fewer modifications in the affinity and density of cardiac-receptors, and few isolated areas of fibrosis in the heart, in mice infected with Trypanosoma cruzi Tulahuen strain or SGO-Z12 isolate and treated at 180 days post infection (p.i.) (i.e. chronic phase) with Benznidazole.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.

Benznidazole (Synonyms: Benznidazol; Ro 07-1051; Ro 71051)